Direct gene delivery strategies for the treatment of rheumatoid arthritis
- 13 February 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (5) , 259-267
- https://doi.org/10.1016/s1359-6446(01)01685-3
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammationGene Therapy, 2000
- IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosionJournal of Clinical Investigation, 2000
- Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG MotifsMolecular Therapy, 2000
- Nonviral gene therapy: promises and challengesGene Therapy, 2000
- Persistent expression of canine factor IX in hemophilia B caninesGene Therapy, 1999
- Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsGene Therapy, 1998
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- Inhibition of Interleukin-1-Induced Effects in Synoviocytes Transduced with the Human IL-1 Receptor Antagonist cDNA Using an Adenoviral VectorHuman Gene Therapy, 1995
- Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In VivoHuman Gene Therapy, 1992